サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は巨細胞性動脈炎の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは巨細胞性動脈炎の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の巨細胞性動脈炎の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは巨細胞性動脈炎の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に巨細胞性動脈炎の治療市場を分類しています。本研究に含まれる主な企業は：Sanofi、Kiniksa Pharmaceuticals, Ltd.、Regeneron、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd.、Novartis AG、AbbVie, Inc.、Bristol-Myers Squibb Company、Abbott、Johnson & Johnson Services, Inc.、Johns Hopkins Hospital、Fortis Healthcare、American College of Rheumatology、Duke University Health System、Lahey Clinic Foundation

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Prednisone
    Methotrexate
    Tocilizumab
    Aspirin

用途別の市場セグメント：
    Corticosteroids
    Immunosuppressive Agents
    Anticoagulants
    Others

本レポートの詳細内容
世界の巨細胞性動脈炎の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、巨細胞性動脈炎の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の巨細胞性動脈炎の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の巨細胞性動脈炎の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、巨細胞性動脈炎の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

巨細胞性動脈炎の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：巨細胞性動脈炎の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：巨細胞性動脈炎の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章巨細胞性動脈炎の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：巨細胞性動脈炎の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：巨細胞性動脈炎の治療の主要企業の概要を提供し、製品の説明と仕様、巨細胞性動脈炎の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
Market Analysis and Insights: Global Giant Cell Arteritis Therapeutic Market
The global Giant Cell Arteritis Therapeutic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Giant Cell Arteritis Therapeutic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Giant Cell Arteritis Therapeutic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Giant Cell Arteritis Therapeutic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Giant Cell Arteritis Therapeutic include Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company and Abbott, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Giant Cell Arteritis Therapeutic is widely used in various fields, such as Corticosteroids, Immunosuppressive Agents, Anticoagulants and Others, etc. Corticosteroids provides greatest supports to the Giant Cell Arteritis Therapeutic industry development. In 2023, global % revenue of Giant Cell Arteritis Therapeutic went into Corticosteroids filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Giant Cell Arteritis Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Giant Cell Arteritis Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Giant Cell Arteritis Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Giant Cell Arteritis Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Giant Cell Arteritis Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Giant Cell Arteritis Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Sanofi
    Kiniksa Pharmaceuticals, Ltd.
    Regeneron
    GlaxoSmithKline plc
    F. Hoffmann-La Roche Ltd.
    Novartis AG
    AbbVie, Inc.
    Bristol-Myers Squibb Company
    Abbott
    Johnson & Johnson Services, Inc.
    Johns Hopkins Hospital
    Fortis Healthcare
    American College of Rheumatology
    Duke University Health System
    Lahey Clinic Foundation

Segment by Type
    Prednisone
    Methotrexate
    Tocilizumab
    Aspirin

Segment by Application
    Corticosteroids
    Immunosuppressive Agents
    Anticoagulants
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Giant Cell Arteritis Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Giant Cell Arteritis Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Giant Cell Arteritis Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Prednisone
    Table 3. Key Players of Methotrexate
    Table 4. Key Players of Tocilizumab
    Table 5. Key Players of Aspirin
    Table 6. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Giant Cell Arteritis Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Giant Cell Arteritis Therapeutic Market Share by Region (2019-2024)
    Table 10. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Giant Cell Arteritis Therapeutic Market Share by Region (2025-2030)
    Table 12. Giant Cell Arteritis Therapeutic Market Trends
    Table 13. Giant Cell Arteritis Therapeutic Market Drivers
    Table 14. Giant Cell Arteritis Therapeutic Market Challenges
    Table 15. Giant Cell Arteritis Therapeutic Market Restraints
    Table 16. Global Giant Cell Arteritis Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Giant Cell Arteritis Therapeutic Revenue Share by Players (2019-2024)
    Table 18. Global Top Giant Cell Arteritis Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2023)
    Table 19. Global Giant Cell Arteritis Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Giant Cell Arteritis Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Giant Cell Arteritis Therapeutic, Headquarters and Area Served
    Table 22. Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
    Table 23. Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2019-2024)
    Table 27. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2025-2030)
    Table 29. Global Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Giant Cell Arteritis Therapeutic Revenue Share by Application (2019-2024)
    Table 31. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Giant Cell Arteritis Therapeutic Revenue Share by Application (2025-2030)
    Table 33. North America Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Giant Cell Arteritis Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Giant Cell Arteritis Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Giant Cell Arteritis Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Giant Cell Arteritis Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Giant Cell Arteritis Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Giant Cell Arteritis Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Giant Cell Arteritis Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Giant Cell Arteritis Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Giant Cell Arteritis Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Giant Cell Arteritis Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Giant Cell Arteritis Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Giant Cell Arteritis Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Giant Cell Arteritis Therapeutic Product
    Table 68. Sanofi Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 69. Sanofi Recent Developments
    Table 70. Kiniksa Pharmaceuticals, Ltd. Company Details
    Table 71. Kiniksa Pharmaceuticals, Ltd. Business Overview
    Table 72. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product
    Table 73. Kiniksa Pharmaceuticals, Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 74. Kiniksa Pharmaceuticals, Ltd. Recent Developments
    Table 75. Regeneron Company Details
    Table 76. Regeneron Business Overview
    Table 77. Regeneron Giant Cell Arteritis Therapeutic Product
    Table 78. Regeneron Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 79. Regeneron Recent Developments
    Table 80. GlaxoSmithKline plc Company Details
    Table 81. GlaxoSmithKline plc Business Overview
    Table 82. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product
    Table 83. GlaxoSmithKline plc Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 84. GlaxoSmithKline plc Recent Developments
    Table 85. F. Hoffmann-La Roche Ltd. Company Details
    Table 86. F. Hoffmann-La Roche Ltd. Business Overview
    Table 87. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product
    Table 88. F. Hoffmann-La Roche Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 89. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 90. Novartis AG Company Details
    Table 91. Novartis AG Business Overview
    Table 92. Novartis AG Giant Cell Arteritis Therapeutic Product
    Table 93. Novartis AG Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 94. Novartis AG Recent Developments
    Table 95. AbbVie, Inc. Company Details
    Table 96. AbbVie, Inc. Business Overview
    Table 97. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product
    Table 98. AbbVie, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 99. AbbVie, Inc. Recent Developments
    Table 100. Bristol-Myers Squibb Company Company Details
    Table 101. Bristol-Myers Squibb Company Business Overview
    Table 102. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product
    Table 103. Bristol-Myers Squibb Company Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 104. Bristol-Myers Squibb Company Recent Developments
    Table 105. Abbott Company Details
    Table 106. Abbott Business Overview
    Table 107. Abbott Giant Cell Arteritis Therapeutic Product
    Table 108. Abbott Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 109. Abbott Recent Developments
    Table 110. Johnson & Johnson Services, Inc. Company Details
    Table 111. Johnson & Johnson Services, Inc. Business Overview
    Table 112. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product
    Table 113. Johnson & Johnson Services, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 114. Johnson & Johnson Services, Inc. Recent Developments
    Table 115. Johns Hopkins Hospital Company Details
    Table 116. Johns Hopkins Hospital Business Overview
    Table 117. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product
    Table 118. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 119. Johns Hopkins Hospital Recent Developments
    Table 120. Fortis Healthcare Company Details
    Table 121. Fortis Healthcare Business Overview
    Table 122. Fortis Healthcare Giant Cell Arteritis Therapeutic Product
    Table 123. Fortis Healthcare Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 124. Fortis Healthcare Recent Developments
    Table 125. American College of Rheumatology Company Details
    Table 126. American College of Rheumatology Business Overview
    Table 127. American College of Rheumatology Giant Cell Arteritis Therapeutic Product
    Table 128. American College of Rheumatology Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 129. American College of Rheumatology Recent Developments
    Table 130. Duke University Health System Company Details
    Table 131. Duke University Health System Business Overview
    Table 132. Duke University Health System Giant Cell Arteritis Therapeutic Product
    Table 133. Duke University Health System Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 134. Duke University Health System Recent Developments
    Table 135. Lahey Clinic Foundation Company Details
    Table 136. Lahey Clinic Foundation Business Overview
    Table 137. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product
    Table 138. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Therapeutic Business (2019-2024) & (US$ Million)
    Table 139. Lahey Clinic Foundation Recent Developments
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Giant Cell Arteritis Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Prednisone Features
    Figure 4. Methotrexate Features
    Figure 5. Tocilizumab Features
    Figure 6. Aspirin Features
    Figure 7. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Giant Cell Arteritis Therapeutic Market Share by Application: 2023 VS 2030
    Figure 9. Corticosteroids Case Studies
    Figure 10. Immunosuppressive Agents Case Studies
    Figure 11. Anticoagulants Case Studies
    Figure 12. Others Case Studies
    Figure 13. Giant Cell Arteritis Therapeutic Report Years Considered
    Figure 14. Global Giant Cell Arteritis Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Giant Cell Arteritis Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Giant Cell Arteritis Therapeutic Market Share by Region: 2023 VS 2030
    Figure 17. Global Giant Cell Arteritis Therapeutic Market Share by Players in 2023
    Figure 18. Global Top Giant Cell Arteritis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Therapeutic Revenue in 2023
    Figure 20. North America Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Giant Cell Arteritis Therapeutic Market Share by Type (2019-2030)
    Figure 22. North America Giant Cell Arteritis Therapeutic Market Share by Application (2019-2030)
    Figure 23. North America Giant Cell Arteritis Therapeutic Market Share by Country (2019-2030)
    Figure 24. United States Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Giant Cell Arteritis Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Giant Cell Arteritis Therapeutic Market Share by Type (2019-2030)
    Figure 28. Europe Giant Cell Arteritis Therapeutic Market Share by Application (2019-2030)
    Figure 29. Europe Giant Cell Arteritis Therapeutic Market Share by Country (2019-2030)
    Figure 30. Germany Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Giant Cell Arteritis Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Giant Cell Arteritis Therapeutic Market Share by Type (2019-2030)
    Figure 38. China Giant Cell Arteritis Therapeutic Market Share by Application (2019-2030)
    Figure 39. Asia Giant Cell Arteritis Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Giant Cell Arteritis Therapeutic Market Share by Type (2019-2030)
    Figure 41. Asia Giant Cell Arteritis Therapeutic Market Share by Application (2019-2030)
    Figure 42. Asia Giant Cell Arteritis Therapeutic Market Share by Region (2019-2030)
    Figure 43. Japan Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Giant Cell Arteritis Therapeutic Market Share by Country (2019-2030)
    Figure 53. Brazil Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Giant Cell Arteritis Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Sanofi Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 60. Kiniksa Pharmaceuticals, Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 61. Regeneron Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 62. GlaxoSmithKline plc Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 63. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 64. Novartis AG Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 65. AbbVie, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 67. Abbott Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 68. Johnson & Johnson Services, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 69. Johns Hopkins Hospital Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 70. Fortis Healthcare Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 71. American College of Rheumatology Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 72. Duke University Health System Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 73. Lahey Clinic Foundation Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed